Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019-Related Hospitalizations in Georgia.

Autor:	Aslanikashvili A; Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway., Rylander C; Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway., Manjavidze T; Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.; Department of Medical Statistics, National Center for Disease Control and Public Health Georgia, Tbilisi, Georgia., Gamkrelidze A; School of Health Sciences, University of Georgia, Tbilisi, Georgia., Baliashvili D; Task Force for Global Health, Tbilisi, Georgia., Anda EE; Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.
Jazyk:	angličtina
Zdroj:	The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. e694-e699.
DOI:	10.1093/infdis/jiae103
Abstrakt:	Background: The aim of this study was to evaluate the impact of hepatitis C virus (HCV) infection and treatment status on coronavirus disease 2019 (COVID-19)-related hospitalizations in Georgia. Methods: We analyzed 2020-2021 Georgian health registry data for COVID-19-positive individuals and categorized the data by HCV infection and treatment status. Logistic regression was used to assess the strengths of the associations. Results: Treated individuals with HCV had lower odds of COVID-19-related hospitalization compared to anti-HCV-negative individuals, while untreated HCV-viremic and anti-HCV-positive nonviremic individuals had higher odds. Conclusions: HCV treatment prior to COVID-19 infection was associated with lower odds of COVID-19-related hospitalization, highlighting the benefits of HCV management in the context of the pandemic. Competing Interests: Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu